Publicaciones
El conocimiento generado en IrsiCaixa se comparte con la comunidad científica a través de la publicación de artículos en revistas científicas de alto impacto.
Inhibition of HIV-1 replication by an improved hairpin ribozyme that includes an RNA decoy.
HIV type 1 fitness evolution in antiretroviral-experienced patients with sustained CD4+ T cell counts but persistent virologic failure.
Measurement of intracellular didanosine and tenofovir phosphorylated metabolites and possible interaction of the two drugs in human immunodeficiency virus-infected patients.
New targets and new drugs in the treatment of HIV.
Combination of a mutagenic agent with a reverse transcriptase inhibitor results in systematic inhibition of HIV-1 infection.
Lopinavir/ritonavir plus nevirapine as a nucleoside-sparing approach in antiretroviral-experienced patients (NEKA study).
[Mutations resulting in resistence of antiretroviral drugs in HIV-infected patients].
The anti-HIV activity of ADS-J1 targets the HIV-1 gp120.
Dynamics of hepatitis C virus NS5A quasispecies during interferon and ribavirin therapy in responder and non-responder patients with genotype 1b chronic hepatitis C.
Multiple products derived from two CCL4 loci: high incidence of a new polymorphism in HIV+ patients.